PMC:7594251 / 124017-124245 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T130","span":{"begin":46,"end":66},"obj":"Disease"},{"id":"T131","span":{"begin":57,"end":66},"obj":"Disease"}],"attributes":[{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"}],"text":"Evaluating response outcome for patients with rheumatoid arthritis, treated with rituximab. Identification of metabolites changes between responders and non-responders such as succinate, taurine, lactate, pyruvate and aspartate."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52066","span":{"begin":81,"end":90},"obj":"Chemical"},{"id":"T80883","span":{"begin":110,"end":121},"obj":"Chemical"},{"id":"T84447","span":{"begin":176,"end":185},"obj":"Chemical"},{"id":"T47403","span":{"begin":187,"end":194},"obj":"Chemical"},{"id":"T99870","span":{"begin":196,"end":203},"obj":"Chemical"},{"id":"T33646","span":{"begin":205,"end":213},"obj":"Chemical"},{"id":"T83140","span":{"begin":218,"end":227},"obj":"Chemical"}],"attributes":[{"id":"A92766","pred":"chebi_id","subj":"T52066","obj":"http://purl.obolibrary.org/obo/CHEBI_64357"},{"id":"A15380","pred":"chebi_id","subj":"T80883","obj":"http://purl.obolibrary.org/obo/CHEBI_25212"},{"id":"A19359","pred":"chebi_id","subj":"T84447","obj":"http://purl.obolibrary.org/obo/CHEBI_26806"},{"id":"A62976","pred":"chebi_id","subj":"T84447","obj":"http://purl.obolibrary.org/obo/CHEBI_30031"},{"id":"A29724","pred":"chebi_id","subj":"T47403","obj":"http://purl.obolibrary.org/obo/CHEBI_15891"},{"id":"A67876","pred":"chebi_id","subj":"T47403","obj":"http://purl.obolibrary.org/obo/CHEBI_507393"},{"id":"A72733","pred":"chebi_id","subj":"T99870","obj":"http://purl.obolibrary.org/obo/CHEBI_24996"},{"id":"A89562","pred":"chebi_id","subj":"T33646","obj":"http://purl.obolibrary.org/obo/CHEBI_15361"},{"id":"A98822","pred":"chebi_id","subj":"T83140","obj":"http://purl.obolibrary.org/obo/CHEBI_132943"},{"id":"A9147","pred":"chebi_id","subj":"T83140","obj":"http://purl.obolibrary.org/obo/CHEBI_29995"},{"id":"A45013","pred":"chebi_id","subj":"T83140","obj":"http://purl.obolibrary.org/obo/CHEBI_72314"}],"text":"Evaluating response outcome for patients with rheumatoid arthritis, treated with rituximab. Identification of metabolites changes between responders and non-responders such as succinate, taurine, lactate, pyruvate and aspartate."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2177","span":{"begin":32,"end":40},"obj":"Species"},{"id":"2274","span":{"begin":81,"end":90},"obj":"Chemical"},{"id":"2275","span":{"begin":176,"end":185},"obj":"Chemical"},{"id":"2276","span":{"begin":187,"end":194},"obj":"Chemical"},{"id":"2277","span":{"begin":196,"end":203},"obj":"Chemical"},{"id":"2278","span":{"begin":205,"end":213},"obj":"Chemical"},{"id":"2279","span":{"begin":218,"end":227},"obj":"Chemical"},{"id":"2357","span":{"begin":46,"end":66},"obj":"Disease"}],"attributes":[{"id":"A2177","pred":"tao:has_database_id","subj":"2177","obj":"Tax:9606"},{"id":"A2274","pred":"tao:has_database_id","subj":"2274","obj":"MESH:D000069283"},{"id":"A2275","pred":"tao:has_database_id","subj":"2275","obj":"MESH:D019802"},{"id":"A2276","pred":"tao:has_database_id","subj":"2276","obj":"MESH:D013654"},{"id":"A2277","pred":"tao:has_database_id","subj":"2277","obj":"MESH:D019344"},{"id":"A2278","pred":"tao:has_database_id","subj":"2278","obj":"MESH:D019289"},{"id":"A2279","pred":"tao:has_database_id","subj":"2279","obj":"MESH:D001224"},{"id":"A2357","pred":"tao:has_database_id","subj":"2357","obj":"MESH:D001172"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Evaluating response outcome for patients with rheumatoid arthritis, treated with rituximab. Identification of metabolites changes between responders and non-responders such as succinate, taurine, lactate, pyruvate and aspartate."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T27","span":{"begin":46,"end":66},"obj":"Phenotype"}],"attributes":[{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0001370"}],"text":"Evaluating response outcome for patients with rheumatoid arthritis, treated with rituximab. Identification of metabolites changes between responders and non-responders such as succinate, taurine, lactate, pyruvate and aspartate."}

{"project":"LitCovid-sentences","denotations":[{"id":"T860","span":{"begin":92,"end":228},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Evaluating response outcome for patients with rheumatoid arthritis, treated with rituximab. Identification of metabolites changes between responders and non-responders such as succinate, taurine, lactate, pyruvate and aspartate."}